Back to search

Pharmenable Therapeutics Limited

10430444

active
ltd
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

C/O Azets, Victory House Vision Park, Histon, Cambridge, CB24 9ZR
Incorporated 17/10/2016

Previously known as

Pharmenable Limited · until 20/07/2023

Compliance

Last accounts

31/01/2026

total exemption full

Next accounts due

31/10/2027

On track

Confirmation statement

Last: 25/02/2026

Due 11/03/2027

On track

Industry

74909
Other professional, scientific and technical activities

Officers

Dr Hannah Fiona Sore

director · Since 17/10/2016

DIRECTOR

BRITISH · ENGLAND

Also on 2 other boards

Dr Jane Elizabeth Dancer

director · Since 11/12/2019

DIRECTOR

BRITISH · UNITED KINGDOM

Also on 5 other boards

Dr Keith Stuart Blundy

director · Since 18/11/2022

CONSULTANT

BRITISH · UNITED KINGDOM

Dr Ian James Collins

director · Since 19/12/2023

DIRECTOR

BRITISH · UNITED KINGDOM

Mr David Ian Ford

director · Since 15/01/2025

NONE

BRITISH · ENGLAND

Also on 10 other boards

Hannah Fiona Sore

director · Since 17/10/2016

British · England

Jane Elizabeth Dancer

director · Since 11/12/2019

British · United Kingdom

Keith Stuart Blundy

director · Since 18/11/2022

British · United Kingdom

Ian James Collins

director · Since 19/12/2023

British · United Kingdom

David Ian Ford

director · Since 15/01/2025

British · England

Former

Natalia Mateu

director · Resigned 18/11/2022

Christine Janet Martin

director · Resigned 18/11/2022

Gaynor Mary Fryers

director · Resigned 29/11/2023

Peter Mcpartland

director · Resigned 15/01/2025

Jeffrey Bernard Moore

director · Resigned 01/07/2026

Mr. Jeffrey Bernard Moore

director · Resigned 01/07/2026

Persons with Significant Control

Former PSCs

Dr Hannah Fiona Sore

Ceased 01/05/2020

Dr Natalie Mateu

Ceased 01/05/2020

Change History

status → active
2026-07-24

Active

type → ltd
2026-07-24

Private Limited Company

address line1 → C/O Azets, Victory House Vision Park
2026-07-24

C/O AZETS, VICTORY HOUSE VISION PARK

post town → Cambridge
2026-07-24

CAMBRIDGE

officer appointed → BLUNDY, Keith Stuart, Dr
2026-07-24
officer appointed → COLLINS, Ian James, Dr
2026-07-24
officer appointed → DANCER, Jane Elizabeth, Dr
2026-07-24
officer appointed → FORD, David Ian
2026-07-24
officer appointed → SORE, Hannah Fiona, Dr
2026-07-24

CompanyRankvs 28270+ SIC 74909 peers
54

Financial strength28th percentile among SIC peers · 7/25
Employees11th percentile among SIC peers · 2/15
LiquidityCurrent ratio 7.8× · 20/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength7/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees2/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/01/2026

Net Worth

£32

Balance sheet strength

Cash

£719k

Cash in the bank

Net Current Assets

£840k

Working capital

Current Assets

£963k

Current Liabilities

£123k

Fixed Assets

£3k

Debtors

£244k

0avg. employees

Balance Sheet

Assets less current liabilities£843k
Prepared with CCH Software

EstimatesDerived

YearCurrent Ratio
20267.80
20267.80
202512.41
202425.04
202347.79

Derived from filed accounts. Not audited figures.